Vaccine Maker
- All
- News
- Videos
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
Vaccine Maker Adar Poonawalla To Buy Mansion In London's Mayfair. It Costs...
Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.
-
"Very Useful For Coming Generations": PM Modi Praises 'The Vaccine War'
Prime Minister Narendra Modi on Thursday congratulated the makers of "The Vaccine War", saying the movie has made every Indian feel proud.
-
US Backs Moderna, Says Government Should Face Covid Vaccine Lawsuit
The USgovernment should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.
-
World's 1st Covid Nasal Vaccine, Made In India, To Be Out On Republic Day
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26.
-
Cooperation Needed To Deal With Future Outbreaks: Adar Poonawalla
Vaccine maker Serum Institute of India CEO Adar Poonawalla has called for global harmonisation or regulatory standards and said that cooperation among multilateral organisations is a must for dealing with future outbreaks.
-
"Covid Situation In India Better Than Elsewhere": Vaccine Maker Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla on Sunday praised India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic in the country.
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
China Covid Surges, Vaccine Maker Adar Poonawalla says "Needn't Panic"
Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".
-
No External Pressure To Accelerate Development Of Covaxin: Bharat Biotech
Covid-19 vaccine Covaxin maker Bharat Biotech today said there was no external pressure on the firm to speed up its development.
-
Moderna Sues Pfizer Over Covid Vaccine
Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their shot for COVID-19.
-
Monkeypox: Centre Invites Bids For Developing Vaccine
The Centre has asked vaccine makers to develop a vaccine for Monkeypox, several cases of which have surfaced in the country. Diagnostic kit manufacturers have been asked to develop diagnostic kits for the disease.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
Vaccine Maker Adar Poonawalla To Buy Mansion In London's Mayfair. It Costs...
Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.
-
"Very Useful For Coming Generations": PM Modi Praises 'The Vaccine War'
Prime Minister Narendra Modi on Thursday congratulated the makers of "The Vaccine War", saying the movie has made every Indian feel proud.
-
US Backs Moderna, Says Government Should Face Covid Vaccine Lawsuit
The USgovernment should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.
-
World's 1st Covid Nasal Vaccine, Made In India, To Be Out On Republic Day
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26.
-
Cooperation Needed To Deal With Future Outbreaks: Adar Poonawalla
Vaccine maker Serum Institute of India CEO Adar Poonawalla has called for global harmonisation or regulatory standards and said that cooperation among multilateral organisations is a must for dealing with future outbreaks.
-
"Covid Situation In India Better Than Elsewhere": Vaccine Maker Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla on Sunday praised India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic in the country.
-
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received.
-
China Covid Surges, Vaccine Maker Adar Poonawalla says "Needn't Panic"
Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record".
-
No External Pressure To Accelerate Development Of Covaxin: Bharat Biotech
Covid-19 vaccine Covaxin maker Bharat Biotech today said there was no external pressure on the firm to speed up its development.
-
Moderna Sues Pfizer Over Covid Vaccine
Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their shot for COVID-19.
-
Monkeypox: Centre Invites Bids For Developing Vaccine
The Centre has asked vaccine makers to develop a vaccine for Monkeypox, several cases of which have surfaced in the country. Diagnostic kit manufacturers have been asked to develop diagnostic kits for the disease.
